Prolung Inc (FRES) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FRES Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Prolung Inc adapts its cash strategy across cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
3 Months
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Operating Activities
Income-0.81
Depreciation & amortization0.00
Amortization of Other Assets0.02
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.16
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Stock Issued-
Loss On Disposition Of Computer Equipment-
Obsolete Inventory-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Shares Issued Under Research Agreement-
Operating Lease Right Of Use Asset Amortization Expense0.01
Exercise Of Warrants For Acquired Research And Development-
Additional Shares Of Common Stock Issued To Warrant Holders-
Issuance Of Common Stock For Acquired Research And Development-
Increase Decrease In Operating Lease Liability-0.01
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.05
Increase (Decrease) in Accrued Liabilities0.21
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.36
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.07
Long-term debt - borrowings0.84
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Convertible Notes-
Payment Of Checks Written In Excess Of Cash Balance-
Proceeds From Issuance Of Relatedparty Notes Payable-
Principal Payments On Relatedparty Notes Payable-
Proceeds From Issuance Of Notes Payable-
Proceeds From Issuance Of Convertible Debentures-
Payment Of Offering Costs-
Offering And Deferred Offering Costs Paid In Cash-
Payment On Third Party Debt-
Payment For Offering And Deferred Offering Costs-
Payment For Loan And Offering Costs-
Payment For Loan And Stock Offering Costs-
Payment For Placement Of Convertible Notes Payable-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.91
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.36
Total Cash Flow0.55
4 historic quarters locked

Sign in to unlock the full Prolung Inc cash flow history.

About Prolung Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-23-018584

Figures are derived from filed reports and may be restated. Historical data is subject to revision.